La chaîne d'options affiche les données clés des options sur actions de Lyra Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Lyra Therapeutics..

Lyra Therapeutics (NASDAQ:LYRA) Stock, Chaîne d'Options

Lyra Therapeutics

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Lyra Therapeutics Inc

U.S. President Donald Trump has declared the signing of deals worth over $200 billion between the United States and the United Arab Emirates (UAE). 
What Happened: A substantial portion of these agreements involves a $14.5 billion commitment from Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) and Etihad Airways. The Abu Dhabi-based airline confirmed on Friday that it has placed an order for 28 wide-body Boeing aircraft fitted with GE engines, reported Reuters.
Etihad Airways stated that the new aircraft, set to join the fleet from 2028, align with the company&#8217;s &#8220;ongoing approach to aligning its fleet with evolving network and operational needs.&#8221; 
According to its CEO Antonoaldo Neves, Etihad plans to add 20 to 22 new planes in 2025 as part of its goal to grow its fleet to over 170 aircraft by 2030 and support Abu Dhabi&#8217;s economic diversification efforts.
The White House earlier announced that Etihad had committed to a $14.5 billion investment to purchase 28 Boeing 787 and 777X aircraft equipped with GE engines. 
SEE ALSO: <a href="https://benzinga.com/tech/25/05/45433850/mr-wonderful-kevin-oleary-says-youre-literally-giving-away-money-to-billers-by-not-doing-this-one-simple-thi" target="_blank" rel="noreferrer noopener">Mr Wonderful Kevin O&#8217;Leary Says You&#8217;re Literally Giving Away Money To Billers By Not Doing This One Simple Thing — And He&#8217;s Been Doing It For Decades</a>
Why It Matters: The deal comes on the heels of President Trump&#8217;s recent $1.2 trillion &#8216;Made in America&#8217; win, where Boeing, GE and other companies secured a mega-deal with Qatar. The economic agreements between the United States and Qatar totaled over $243.5 billion, which included a significant sale of Boeing aircraft and GE Aerospace <a href="https://www.benzinga.com/news/contracts/25/05/45434792/trumps-12-trillion-made-in-america-win-boeing-ge-and-others-secure-qatar-mega-deal">engines </a>to Qatar Airways for $96 billion.
However, economist Peter Schiff warned that such massive deals could potentially spike US inflation and interest rates, citing America&#8217;s structural vulnerabilities. Schiff highlighted the potential financial <a href="https://www.benzinga.com/general/travel/25/05/45427289/peter-schiff-warns-qatars-200-billion-boeing-deal-could-spike-us-inflation-interest-rates-says-treasury-sell-off-may-follow">fallout </a>of Boeing's mega deal with Qatar, which involves acquiring 160 jets for its state-owned carrier, Qatar Airways.
Boeing holds a momentum rating of 90.53% and a growth rating of 12.20%, according to <a href="https://www.benzinga.com/quote/BA" target="_blank" rel="noreferrer noopener">Benzinga's Proprietary Edge Rankings</a>. The Benzinga Growth metric evaluates a stock&#8217;s historical earnings and revenue expansion across multiple timeframes, prioritizing both long-term trends and recent performance. 
<ul class="wp-block-list">
<li>READ MORE: <a href="https://benzinga.com/markets/cryptocurrency/25/05/45450026/bitcoin-holding-up-while-ethereum-xrp-dogecoin-dip-dont-get-distracted-by-short-term-noise-trader-says" target="_blank" rel="noreferrer noopener">Bitcoin Holding Up While Ethereum, XRP, Dogecoin Dip: &#8216;Don&#8217;t Get Distracted By Short Term Noise,&#8217; Trader Says &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

News

Markets

Trump Announces $200 Billion In US-UAE Deals, Etihad Orders 28 Boeing Jets Worth $14.5 Billion

<h3>Companies Reporting Before The Bell</h3>
• Mastech Digital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MHH#AMEX">MHH</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $49.68 million. 
• Flowers Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $1.60 billion. 
• Codere Online Luxembourg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDRO#NASDAQ">CDRO</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $53.57 million. 
• Dingdong (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) is expected to report earnings for its first quarter. 
• Yatsen Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) is estimated to report earnings for its first quarter. 
• ATA Creativity Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) is estimated to report earnings for its first quarter. 
• RLX Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) is projected to report earnings for its first quarter. 
• Brady (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>) is expected to report quarterly earnings at $1.22 per share on revenue of $386.61 million. 
• So-Young Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) is estimated to report earnings for its first quarter. 
• RBC Bearings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) is likely to report quarterly earnings at $2.70 per share on revenue of $440.26 million. 
<h3>Companies Reporting After The Bell</h3>
• Armlogi Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOC#NASDAQ">BTOC</a>) is likely to report earnings for its third quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

AACG

BTOC

CDRO

Earnings Scheduled For May 16, 2025

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Thursday.
U.S. stocks settled mixed on Thursday, with the S&amp;P 500 recording gains for the fourth straight session. Week to date, the S&amp;P 500 gained around 4.5%, while the Dow added around 2.6%. The Nasdaq has added around 6.6% during the period.
Tech giants have also recorded sharp gains during the week, with Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) adding around 15% each. Shares of Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) gained around 6%, while Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) jumped 7% week-to-date.
Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) reported better-than-expected earnings for its first quarter on Thursday. Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) shares jumped around 86% on Thursday after DICK's Sporting Goods agreed to acquire the company.
On the economic data front, initial jobless claims came in unchanged from the previous week at 229,000 during the week ending May 10. U.S. retail sales increased by 0.1% month-over-month in April compared to a revised 1.7% gain in March. U.S. producer prices declined by 0.5% in April compared to a revised flat reading in the previous month and versus market estimates of a 0.2% gain.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, consumer staples and real estate stocks recording biggest gains on Thursday. However, consumer discretionary and communication services stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 272 points to 42,322.75 on Thursday. The S&amp;P 500 gained 0.41% to 5,916.93, while the Nasdaq Composite fell 0.18% at 19,112.32 during Thursday's session.
Investors are awaiting earnings results from Flowers Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>), Brady Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>) and RBC Bearings Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) today.
At a current reading of 68.9, the index remained in the &#8220;Greed&#8221; zone on Thursday, versus a prior reading of 70.4.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Trading Ideas

AMZN

GOOGL

NVDA

TSLA

S&P 500 Settles Higher For Fourth Session Amid Surge In Tech Stocks: Investor Sentiment Slips, But Fear Index Stays In 'Greed' Zone

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul class="wp-block-list">
<li>Wall Street expects Flowers Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>) to report quarterly earnings at 38 cents per share on revenue of $1.60 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Flowers Foods shares fell 0.1% to $17.05 in after-hours trading.</li>
<li>Applied Materials Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) reported better-than-expected earnings for its second quarter, while sales missed estimates. Applied Materials said it expects third-quarter revenue of $7.2 billion, plus or minus $500 million, versus estimates of $7.19 billion. The company expects third-quarter adjusted earnings to be between $2.15 and $2.55 per share, versus estimates of $2.32 per share. Applied Materials shares dipped 5.6% to $165.00 in the after-hours trading session.</li>
<li>Analysts are expecting Brady Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>) to post quarterly earnings at $1.22 per share on revenue of $386.81 million. The company will release earnings before the markets open. Brady shares gained 2.3% to $78.00 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul class="wp-block-list">
<li>Take-Two Interactive Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) reported fourth-quarter net bookings of $1.58 billion, up 17% year-over-year. The total beat a Street consensus estimate of $1.55 billion according to data from Benzinga Pro. The company said it expects first quarter net bookings to be in a range of $1.25 billion to $1.30 billion. The company guides for full fiscal-year net bookings to be in a range of $5.90 billion to $6.00 billion. Take-Two Interactive shares fell 3% to $225.30 in the after-hours trading session.</li>
<li>Analysts expect RBC Bearings Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) to report quarterly earnings at $2.70 per share on revenue of $440.26 million before the opening bell. RBC Bearings shares slipped 0.01% to $367.25 in after-hours trading.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo: Shutterstock

Long Ideas

AMAT

TTWO

Applied Materials, Flowers Foods And 3 Stocks To Watch Heading Into Friday

Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) asked a federal judge on Thursday to throw out the Federal Trade Commission&#8217;s antitrust case, arguing the agency failed to prove Meta maintained an illegal social media monopoly through its acquisitions of Instagram and WhatsApp.
What Happened: The request comes midway through a high-stakes trial that began April 14, where the FTC has sought to establish that Meta dominated the market for social platforms used to share updates with friends and family, Reuters reported. The FTC is seeking to unwind Meta&#8217;s acquisitions of Instagram and WhatsApp, deals completed more than a decade ago.
Meta argues the evidence presented at trial shows WhatsApp had no plans to expand into a social network rival to Facebook, and that Instagram only grew after its acquisition. The company also contends the FTC failed to meaningfully distinguish between supposed friends-and-family sharing apps and content platforms like TikTok.
&#8220;The through line connecting all of these social apps is that each vies to show the most compelling user-generated content so that it can take as much user time and attention as possible from the other apps, including Meta&#8217;s apps,&#8221; the company said in its filing.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45460177/bitcoin-rises-while-ethereum-dogecoin-slip-market-isnt-going-to-peak-in-the-next-6-months-says-popular-analyst">Bitcoin Rises While Ethereum, Dogecoin Slip — &#8216;Market Isn&#8217;t Going To Peak In The Next 6 Months,&#8217; Says Popular Analyst</a>
Why It Matters: The FTC&#8217;s case centers on allegations that Meta employed a &#8220;buy or bury&#8221; <a href="https://www.benzinga.com/25/04/44821791/meta-platforms-used-buy-or-bury-strategy-to-monopolize-social-media-ftc-says">strategy to neutralize competition</a>. Prosecutors highlighted a 2008 email where CEO Mark Zuckerberg reportedly stated it was &#8220;better to buy than compete,&#8221; framing the acquisitions as tactics to eliminate rising competitors.
Zuckerberg, who testified for three hours on the trial&#8217;s first day, <a href="https://www.benzinga.com/25/04/44821791/meta-platforms-used-buy-or-bury-strategy-to-monopolize-social-media-ftc-says">argued the acquisitions were necessary to adapt</a> to evolving user preferences and pointed to competition from TikTok and YouTube Shorts as evidence of a dynamic market.
U.S. District Judge James Boasberg could decline to rule on Meta&#8217;s request and allow the trial to continue into June, the report noted. If he doesn&#8217;t grant Meta&#8217;s motion, both sides will file final briefs and present closing arguments after Meta completes its evidence presentation.
Former FTC Chair Lina Khan, who stepped down in January, previously stated there is &#8220;no expiration date when it comes to the illegality of the transaction,&#8221; underscoring the agency&#8217;s position that Meta&#8217;s acquisitions remain <a href="https://www.benzinga.com/general/social-media/25/04/44799581/no-expiration-date-on-metas-antitrust-case-says-former-ftc-chair-ahead-of-trial">subject to regulatory scrutiny</a>.
Photo Courtesy: Skorzewiak on Shutterstock.com
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/management/25/05/45455434/warren-buffett-ditches-bitcoin-linked-nu-holdings-adds-to-constellation-brands-dominos-pizza-pool-corp-stakes" target="_blank" rel="noreferrer noopener">Warren Buffett Ditches Bitcoin-Linked Nu Holdings, Adds To Constellation Brands, Domino's Pizza, Pool Corp Stakes</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Meta Asks Judge To Dismiss FTC Antitrust Case Mid-Trial, Says Instagram, WhatsApp Deals Didn't Create Monopoly

Mediterranean fast-casual chain CAVA Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) is confidently progressing towards its ambitious goal of operating 1,000 restaurants by 2032, the company announced during its first-quarter 2025 earnings call.
What Happened: Despite broader economic uncertainties and potential headwinds, CEO Brett Schulman emphasized the brand&#8217;s strong momentum and reaffirmed its long-term strategic vision.
&#8220;We are well on our way to our goal of at least 1,000 restaurants by 2032, creating more spaces where connection, community, and Mediterranean hospitality can thrive,&#8221; Schulman stated during the call.
This expansion is being fueled by a robust first quarter, which saw a healthy 10.8% growth in same-restaurant sales, driven by a significant 7.5% rise in traffic.
The company also opened 15 new restaurants in the quarter, bringing its total count to 382.
Adding to investor confidence, Schulman addressed concerns regarding the potential impact of Donald Trump&#8216;s tariffs on the company&#8217;s supply chain. &#8220;That said, our exposure remains limited based on the current policies, which are fluid, given that the majority of our ingredients are domestically sourced or covered under existing contracts,&#8221; he added.
CAVA also celebrated surpassing $1 billion in revenue on a trailing 12-month basis, a significant milestone highlighting its leadership in the category. &#8220;A milestone that is a testament to Mediterranean becoming the next large-scale cultural cuisine category, a category we have firmly established our leadership in,&#8221; Schulman noted.
The company also highlighted the success of its reimagined loyalty program, which has seen sales through the program increase by 340 basis points as a percentage of total revenue, with membership approaching 8 million.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest">Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of &#8216;Compound Interest&#8217;</a>
Why It Matters: The Mediterranean fast-casual restaurant chain company&#8217;s <a href="https://www.benzinga.com/general/restaurants/25/05/45453995/cava-group-reports-q1-earnings-revenue-jumps-28-company-bumps-up-new-restaurant-openings-guidance">first-quarter revenue</a> increased 28.2% year-over-year to $331.83 million, beating the consensus estimate of $326.88 million, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
It also reported first-quarter adjusted earnings of 22 cents per share, beating analyst estimates of 14 cents per share.
CAVA maintains its previous forecast for full-year same-restaurant sales growth at 6% to 8%, while increasing its new restaurant opening projections for the year to between 64 and 68, up from the prior range of 62 to 66.
Shares of CAVA fell 0.48% on Thursday. The stock was down 14% on a year-to-date basis, but 28.12% higher over a year.
Benzinga Edge Stock Rankings shows that CAVA had a stronger price trend over the short term but a weaker trend over the medium and long term. Its momentum ranking was moderate at the 46.27th percentile, whereas its value ranking was poor at the 8.76th percentile; the details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>. 
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/CAVA"><img loading="lazy" decoding="async" width="1024" height="145" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16024411/CAVA-EDGE-1024x145.png" alt="" class="wp-image-917501" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16024411/CAVA-EDGE-1024x145.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16024411/CAVA-EDGE-300x42.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16024411/CAVA-EDGE-768x109.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16024411/CAVA-EDGE.png 1210w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher on Thursday. The SPY was up 0.49% to $590.46, while the QQQ advanced 0.11% to $519.25, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45399783/gordon-johnson-warns-of-potential-liberation-day-20-as-30-year-treasury-yields-approach-5-amid-dollar-weakness">Gordon Johnson Warns Of Potential &#8216;Liberation Day 2.0&#8217; As 30-Year Treasury Yields Approach 5% Amid Dollar Weakness</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: courtesy of CAVA

Earnings Beats

Market Summary

Broad U.S. Equity ETFs

Guidance

Futures

ETFs

General

CAVA

CAVA On Track With Ambitious Expansion Plans Of Having 1,000 Restaurants By 2032: Trump Tariff 'Exposure Remains Limited,' Says CEO

Despite the <a href="https://www.benzinga.com/markets/equities/25/05/45430137/trump-had-a-problem-with-tim-cook-president-says-he-told-apple-ceo-i-dont-want-you-building-in-india-amid-tariff-concerns-and-production-shift-from-china">recent criticism from U.S.</a> President Donald Trump, India remains committed to its growing partnership with Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
What Happened: The Tim Cook-led company has reassured the Indian government of its commitment to continue using India as a major manufacturing base. This assurance comes despite Trump&#8217;s recent remarks, with government sources emphasizing that there is &#8220;no change&#8221; in Apple&#8217;s investment plans in India, as <a href="https://www.cnbctv18.com/technology/apple-manufacturing-us-president-donald-trump-comments-india-reaction-19605132.htm">per</a> a CNBC-TV18 report.
Rajoo Goel, Secretary General of the Electronic Industries Association of India (ELCINA), responded to Trump&#8217;s criticism by underplaying its potential impact. He suggested that while it may slightly slow things down, it is unlikely to significantly affect India, given its minor share in Apple&#8217;s global market. 
Goel referred to Trump&#8217;s remarks as &#8220;just a statement,&#8221; asserting that India&#8217;s electronics manufacturing sector is on &#8220;a very strong footing.&#8221; The Secretary General also anticipates that President Trump would change his stance on this matter.
Apple did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment.
Another Indian government official told India Today that companies like Apple make decisions based on global competitiveness rather than political rhetoric. &#8220;Apple would be more concerned about where they would find manufacturing competitiveness,&#8221; stated the official.
SEE ALSO:&nbsp;<a href="https://benzinga.com/tech/25/05/45433850/mr-wonderful-kevin-oleary-says-youre-literally-giving-away-money-to-billers-by-not-doing-this-one-simple-thi" target="_blank" rel="noreferrer noopener">Mr Wonderful Kevin O&#8217;Leary Says You&#8217;re Literally Giving Away Money To Billers By Not Doing This One Simple Thing — And He&#8217;s Been Doing It For Decades</a>
Why It Matters: Trump&#8217;s recent criticism of Apple&#8217;s manufacturing expansion in India comes after he revealed that he had a &#8220;little problem&#8221; with Apple CEO Tim Cook about the tech giant's manufacturing expansion in India. This followed a conversation between Trump and Cook, where Trump stated that Cook intends to <a href="https://www.benzinga.com/markets/25/05/45417037/apple-may-up-its-numbers-amid-china-tariff-truce-trump-talks-500-billion-us-investment-after-tim-coo">boost </a>Apple's investment in U.S. operations.
However, CNBC's Jim Cramer warned that <a href="https://www.benzinga.com/government/regulations/25/05/45435170/jim-cramer-says-this-will-hurt-apple-president-trump-making-it-tough">Apple could face challenges</a> in India due to Trump's trade policies. He stated that Trump is making it tough for Apple in India, potentially hurting the tech giant&#8217;s operations. Meanwhile, reports suggest that Apple is considering raising prices for its upcoming iPhones but would avoid revealing that the potential hike is related to U.S. tariffs on Chinese-made parts, where most of its assembly takes place.
Despite these criticisms, India&#8217;s electronics industry remains optimistic about its partnership with Apple, suggesting that Trump&#8217;s comments are unlikely to have a significant impact on their ongoing operations. That being said, Apple&#8217;s high-end models like the Pro and Pro Max will continue to be made mainly in China, as India&#8217;s infrastructure and technical capabilities are not yet sufficient for large-scale production at that level, as per experts.
Apple holds a momentum rating of 61.99% and a quality rating of 75.73%, according to&nbsp;<a href="https://www.benzinga.com/quote/AAPL" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s Proprietary Edge Rankings</a>. 
Apple stock has declined 13.29% during the year-to-date period.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/05/45450026/bitcoin-holding-up-while-ethereum-xrp-dogecoin-dip-dont-get-distracted-by-short-term-noise-trader-says" target="_blank" rel="noreferrer noopener">Bitcoin Holding Up While Ethereum, XRP, Dogecoin Dip: &#8216;Don&#8217;t Get Distracted By Short Term Noise,&#8217; Trader Says &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

AAPL

'No Change' In Apple's Production Plans, Says India, Despite Trump's 'Little Problem' With CEO Tim Cook: Report

ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) will release its first-quarter earnings results before the <a href="https://www.benzinga.com/quote/ZIM/earnings">opening bell on Monday, May 19.</a>
Analysts expect the Haifa, Israel-based company to report quarterly earnings at $1.96 per share, up from 75 cents per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, ZIM Integrated Shipping projects quarterly revenue at $1.84 billion, compared to $1.56 billion a year earlier.
On March 12, ZIM Integrated Shipping reported a fourth-quarter sales increase of 80% year over year to $2.17 billion, beating the consensus of $2.06 billion.
ZIM Integrated Shipping shares fell 1.4% to close at $18.03 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/zim/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Jefferies analyst Omar Nokta maintained a Hold rating and raised the price target from $15 to $16 on May 13, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Citigroup analyst Sathish Sivakumar downgraded the stock from Neutral to Sell and boosted the price target from $11.6 to $13 on June 6, 2024. This analyst has an accuracy rate of 64%.</li>
</ul>
Considering buying ZIM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image is-resized"><img decoding="async" src="blob:https://editorial.benzinga.com/018bec95-6339-41db-ac20-6347b3bea363" alt="" style="width:623px;height:auto" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

Top Wall Street Forecasters Revamp ZIM Integrated Shipping Services Expectations Ahead Of Q1 Earnings

RBC Bearings Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) will release its fourth-quarter earnings results before the <a href="https://www.benzinga.com/quote/RBC/earnings">opening bell on Friday, May 16.</a>
Analysts expect the Oxford, Connecticut-based company to report quarterly earnings at $2.7 per share, up from $2.47 per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, RBC Bearings projects quarterly revenue at $440.26 million, compared to $413.68 million a year earlier.
On Jan. 31, RBC Bearings reported better-than-expected third-quarter financial results and issued fourth-quarter net sales guidance above estimates.
RBC Bearings shares gained 0.8% to close at $367.27 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/RBC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Truist Securities analyst Michael Ciarmoli maintained a Buy rating and cut the price target from $410 to $375 on April 17, 2025. This analyst has an accuracy rate of 82%.</li>
<li>Morgan Stanley analyst Kristine Liwag maintained an Overweight rating and boosted the price target from $360 to $390 on Feb. 4, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Keybanc analyst Steve Barger maintained an Overweight rating and raised the price target from $375 to $395 on Feb. 3, 2025. This analyst has an accuracy rate of 73%.</li>
<li>B of A Securities analyst Ronald Epstein downgraded the stock from Buy to Neutral and raised the price target from $330 to $335 on Nov. 21, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Raymond James analyst Tim Thein initiated coverage on the stock with a Market Perform rating on June 28, 2024. This analyst has an accuracy rate of 70%.</li>
</ul>
Considering buying RBC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="571" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-1024x571.png" alt="" class="wp-image-917522" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-1024x571.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

RBC Bearings Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

<ul>
<li>Invisalign Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal expanders.</li>
<li>With Invisalign First&#x2122; aligners and Invisalign&#xAE; Palatal Expanders, Align Technology now provides doctors with a full early intervention treatment solution, including both skeletal (orthopedic) and dental (orthodontic) arch expansion.</li>
</ul>

ALGN

Reported Earlier, Align's Invisalign Palatal Expander System Cleared By NMPA, Set For Commercial Launch In China In Second Half Of 2025

Multinational retailer Walmart Inc.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) e-commerce businesses turned profitable for the first time in the U.S. and globally during the first quarter of the ongoing fiscal year despite looming tariff uncertainties.
What Happened: CEO Doug McMillon expressed optimism over the company&#8217;s e-commerce initiatives during the earnings call and highlighted that it&#8217;s not only serving its customers and members but also making their business more profitable with higher returns over time.
&#8220;We achieved eCommerce profitability, both in the U.S. as well as for the global enterprise in Q1 for the first time, an important milestone for our company,&#8221; he said.
Globally, Walmart&#8217;s e-commerce business grew by 22%, with each segment delivering growth of at least 20%.
The three segments of its e-commerce businesses encompassed growth from Walmart U.S., Walmart International, and its Sam&#8217;s Club U.S. businesses.
&#8220;We&#8217;re encouraged by the fact that eCommerce growth across all three segments continues to be strong, all three segments growing more than 20%,&#8221; added McMillon.
Meanwhile, while addressing the tariff issue, he thanked President Donald Trump and Treasury Secretary Scott Bessent for the progress made recently. He hoped for a longer-term agreement with China amid the ongoing 90-day pause.
However, he added that &#8220;We will do our best to keep our prices as low as possible. But given the magnitude of the tariffs, even at the reduced levels announced this week, we aren&#8217;t able to absorb all the pressure given the reality of narrow retail margins.&#8221;
&#8220;All of the tariffs create cost pressure for us, but the larger tariffs on China have the biggest impact,&#8221; explained McMillon.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest">Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of &#8216;Compound Interest&#8217;</a>
Why It Matters: Walmart&#8217;s <a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">first-quarter revenue</a> marginally missed the analyst consensus estimate of $165.88 billion and came in at $165.60 billion, higher by 2.5% year-on-year.
It reported adjusted EPS of 61 cents, beating the consensus estimate of 58 cents.
Walmart anticipates second-quarter fiscal year 2026 sales to increase by 3.5% to 4.5% on a constant currency basis, projecting revenues between $173.67 billion and $175.35 billion. This range falls slightly below the consensus estimate of $175.21 billion.
Shares of WMT fell 0.50% on Thursday. However, the stock was up 7.06% on a year-to-date basis and 50.52% higher over a year.
Benzinga Edge Stock Rankings shows that WMT had a stronger price trend over the short, medium, and long term. Its momentum ranking was solid at the 92.66th percentile, whereas its value ranking was moderate at the 46.64th percentile; the details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="145" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-1024x145.png" alt="" class="wp-image-917474" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-1024x145.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-768x109.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE.png 1227w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher on Thursday. The SPY was up 0.49% to $590.46, while the QQQ advanced 0.11% to $519.25, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Friday, the futures of the S&amp;P 500, Dow Jones and Nasdaq 100 indices were trading flat. 
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45399783/gordon-johnson-warns-of-potential-liberation-day-20-as-30-year-treasury-yields-approach-5-amid-dollar-weakness">Gordon Johnson Warns Of Potential &#8216;Liberation Day 2.0&#8217; As 30-Year Treasury Yields Approach 5% Amid Dollar Weakness</a></li>
</ul>
image via shutterstock

Earnings Misses

Walmart E-Commerce Turns Profitable For The First Time: Despite Reduced Tariffs, CEO Says Full Impact Can't Be Absorbed, Price Hikes Likely

Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.&nbsp;

WENN

WENNU

Reported Earlier, Wen Acquisition Corp Launches $261M Initial Public Offering Of 26.1M Units At $10/Unit

Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments.&nbsp;

IPOs

CCCMU

Reported Earlier, Columbus Circle Capital I Launches $220M Initial Public Offering Of 22M Units At $10/Unit

TruGolf Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 125 percent. This is a 59.09 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $5.39 million which missed the analyst consensus estimate of $5.64 million by 4.53 percent. This is a 7.52 percent increase over sales of $5.01 million the same period last year.

TRUG

TruGolf Holdings Q1 EPS $(0.09) Misses $(0.04) Estimate, Sales $5.39M Miss $5.64M Estimate

Reading Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDI#NASDAQ">RDI</a>) reported quarterly losses of $(0.21) per share. This is a 61.11 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $40.20 million which beat the analyst consensus estimate of $38.97 million by 3.17 percent. This is a 10.77 percent decrease over sales of $45.05 million the same period last year.

Reading Intl Q1 EPS $(0.21) Up From $(0.54) YoY, Sales $40.20M Beat $38.97M Estimate

SENS

Reported Earlier, Senseonics Prices $50M Public Offering Of 100M Common Shares At $0.50 Per Share

WeRide Launches Fully Driverless Robotaxi Trials in Abu Dhabi, Expands Service to Al Maryah And Al Reem Islands

Jim Cramer weighed in on the deepening crisis at one of America&#8217;s largest health insurers, which has lately found itself under intense scrutiny by the public, regulators, and the media. 
What Happened: On Thursday, Cramer commented on UnitedHealth Group Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) mounting troubles, zeroing in on the company&#8217;s public denial of a Wall Street Journal report about a federal criminal probe, on his X account.
&#8220;UnitedHealth is denying the WSJ story about them,&#8221; Cramer posted, before calling it &#8220;crucial,&#8221; and adding that &#8220;if convicted of criminal Medicare fraud, well, I don&#8217;t know…&#8221; regarding the stock. The CNBC host&#8217;s remarks reflect the uncertainty now gripping the markets and investors as scrutiny over UnitedHealth intensifies.
See More: <a href="https://www.benzinga.com/markets/options/25/05/45460072/wall-street-getting-nervous-magnificent-7-giants-face-33m-bet-against-them-as-market-turbulence-looms">Wall Street Getting Nervous? Magnificent 7 Giants Face $33M Bet Against Them As Market Turbulence Looms</a>
According <a href="https://www.wsj.com/us-news/unitedhealth-medicare-fraud-investigation-df80667f">to</a> the WSJ report, the Justice Department's criminal healthcare fraud division has been investigating UnitedHealth since at least last summer. The probe reportedly centers on billing practices tied to its Medicare Advantage program.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">United Health is denying the WSJ story about them. Crucial because if convicted of criminal Medicare fraud, well, i don&#39;t know&#8230;
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1923018153350631806?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Besides this, the company is facing a barrage of issues, with several other lawsuits from customers, investors, and regulators, the <a href="https://benzinga.com/content/45375716/stat-unitedhealth-stock-tumbles-as-ceo-resigns-2025-outlook-pulled">abrupt exit of its CEO</a> early this week, and a stock that has lost nearly half its value since April.
Why It Matters: The company <a href="https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoil-after-ceo-shake-up">pushed back against</a> the report when Benzinga reached out to them on Thursday. Saying that they have &#8220;not been notified of any criminal investigation,&#8221; and that they stand by &#8220;the integrity of our Medicare Advantage business,&#8221; while calling WSJ&#8217;s reporting as &#8220;deeply irresponsible.&#8221;
UnitedHealth Group has faced a string of negative catalysts over the past couple of months, starting with <a href="https://www.benzinga.com/general/health-care/24/12/42316904/unitedhealthcare-ceo-brian-thompson-fatally-shot-outside-nyc-hotel">the assassination</a> of its subsidiary, UnitedHealthcare&#8217;s CEO, Brian Thompson, in December 2024. Since then, the company has faced lawsuits from investors, who claim the company hid the potential impact of this assassination.
Early this month, Cramer <a href="https://benzinga.com/trading-ideas/long-ideas/25/05/45133450/jim-cramer-this-consumer-cyclical-stock-is-a-one-trick-pony">changed his stance</a> on the stock, saying that he would &#8220;indeed start a position&#8221; in the stock at $400 a share after being &#8220;very negative&#8221; on it. The stock has since dropped 31% in the preceding two weeks.
Price Action: Shares of UnitedHealth were down 10.93% on Thursday, despite the company dismissing claims of a federal criminal investigation. It is up 1.29% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="141" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1024x141.png" alt="" class="wp-image-917435" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1024x141.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-768x106.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1536x212.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The stock fares poorly across most metrics in Benzinga&#8217;s Edge Stock Rankings. It&#8217;s competitor Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) does considerably better. You can find out more <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a>.
Photo courtesy: katz / Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/management/25/05/45456642/bill-ackman-loads-up-on-uber-dumps-nike-in-major-q1-portfolio-rebalance">Bill Ackman Loads Up On Uber In Major Q1 Portfolio Rebalance (CORRECTED)</a></li>
</ul>

Government

Health Care

Jim Cramer Reacts As UnitedHealth Denies  Report On Criminal Probe—'If Convicted of Criminal Medicare Fraud…'

Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) executive chairman, Michael Saylor, says the company, formerly known as MicroStrategy, could survive a brutal crypto winter, but its shareholders wouldn&#8217;t be too happy about it.
What Happened: In a new Financial Times <a href="https://www.ft.com/video/4d1a1666-20d4-4930-ab80-eda742640f16">film</a> and subsequent interviews, Saylor warned that if Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) "fell 90 per cent and stayed there for four or five years, we would still be stable," yet equity investors "would suffer because they're levered."
The alert comes as MicroStrategy — already the world's largest corporate holder of the token at <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45349057/strategy-buys-134b-in-bitcoin-at-99856-cites-155-btc-yield">568,840 BTC</a> worth about $59 billion — keeps piling on debt and preferred-stock financings to buy more.
Saylor's endgame is simple. "Whoever gets the most bitcoin wins. There is no other endgame," he told Yahoo Finance in a separate <a href="https://finance.yahoo.com/news/michael-saylor-is-never-selling-microstrategys-bitcoin-100028211.html?guccounter=1&amp;guce_referrer=aHR0cHM6Ly9mb3J0dW5lLmNvbS8&amp;guce_referrer_sig=AQAAAA0_cDmg_yzUnWkCMGRMws58uA4m5pNkrk4-fuSqVHXxJeAqApmq-qjKyHiettjO_4mfIipQjgHmdG2p97lFQnQfbvQQg0dLC4Tgwo-eU1W42llt5dsynyG1hJipd6xQTyFtZKKAI45R8vcaavU9Jl8y8caZOu2-ZCAa2-MKJf6W">sit-down</a>. To keep buying, MicroStrategy sold $580 million of dividend-paying <a href="https://www.barrons.com/articles/microstrategy-preferred-stock-yield-bb1b45ef">preferred shares</a> in January and another perpetual-preferred slug in March — cash it can deploy straight into crypto.
The balance sheet now holds just $60.3 million in cash against tens of billions in digital assets, its latest 10-Q shows. Former Bank of America ECM chief Craig Coben tells FT that Strategy&#8217;s focus on "new money" raises "questions about the sustainability" of the bet if prices crater.
See also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45417306/michael-saylors-bitcoin-strategy-infinite-money-glitch-or-a-reflexive-leverage-bet">Michael Saylor&#8217;s Bitcoin Strategy—&#8217;Infinite Money Glitch&#8217; Or A Reflexive Leverage Bet?</a>
Saylor shrugs at the skeptics, even <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44044388/michael-saylor-says-sell-a-kidney-but-keep-the-bitcoin-but-mstr-is-down-28-since-he-appeared-on-the-cover-of-forbes">trolling them</a> on X: "Sell a kidney if you must, but keep the Bitcoin." But Saylor's own warning shows just how thin the ice could get if the next crypto winter proves deeper and longer than the last.
Top 3 Bitcoin-Holding Public Companies
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Company Name</td>
<td>Amount Of BTC Held</td>
<td>Value In U.S. Dollars</td>
</tr>
<tr>
<td>MicroStrategy</td>
<td>568,840 BTC</td>
<td>59.16 billion</td>
</tr>
<tr>
<td>Marathon Digital</td>
<td>46,374 BTC</td>
<td>4.82 billion</td>
</tr>
<tr>
<td>Riot Platforms</td>
<td>18,692 BTC</td>
<td>1.94 billion</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Coingecko.</figcaption></figure>
Why It Matters: Economist Peter Schiff, a fierce critic of all things Bitcoin, has consistently questioned Strategy's Bitcoin playbook, recently predicted &#8220;<a href="https://www.benzinga.com/markets/25/05/45426766/peter-schiff-predicts-fireworks-says-michael-saylors-strategy-will-see-unrealized-loss-during-bitcoi">fireworks</a>&#8221; if Bitcoin were to drop in value. Schiff stated that a significant BTC slump could soon even push MSTR "into the red."
That said, JPMorgan analysts expect <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45444794/bitcoin-is-starting-to-outperform-gold-jpmorgan">continued Bitcoin upside</a> into late 2025, driven by sector-specific momentum and weakening gold sentiment. Major U.S. exchanges like Coinbase, Kraken, and Gemini are expanding regulated crypto derivatives offerings to institutional investors, all adding to the crypto king&#8217;s momentum.
Price Action: Shares of MicroStrategy closed 4.73% lower at $397.03 on Thursday. The stock has gained 32.34% since the beginning of 2025, <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">according to data from Benzinga Pro</a>.
Benzinga Edge Stock Rankings indicate that Strategy has a Momentum in the 97th percentile. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-3/?adType=quotepage&amp;campaign=ranking&amp;ad=rankingv1">Click here</a> to see how rivals like Coinbase stack up in comparison.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-3/?adType=quotepage&amp;campaign=ranking&amp;ad=rankingv1"><img loading="lazy" decoding="async" width="1024" height="148" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-1024x148.png" alt="" class="wp-image-917437" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-1024x148.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-768x111.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-1536x222.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge.png 1620w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Photo Courtesy: Bukhta Yurii On Shutterstock.com
Read next: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45449661/eric-trump-bitcoin-accumulation-is-a-race-to-the-top">Eric Trump: Bitcoin Accumulation Is &#8216;A Race To The Top&#8217;</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MARA

MSTR

RIOT

Michael Saylor Says Strategy Inc. Shareholders Could 'Suffer' If Bitcoin Plunges 90% For Half A Decade, But Reveals A Winning Endgame

&#8216;The Big Short&#8217; famed investor Michael Burry, who accurately predicted the 2008 housing market crash, has turned bearish on most equities while doubling his stake in cosmetics giant Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) during the first quarter, according to 13F regulatory filings with the Securities and Exchange Commission on Thursday.
What Happened: Burry&#8217;s Scion Asset Management increased its position in Estée Lauder to 200,000 shares from 100,000 shares at the end of the fourth quarter, despite EL stock being down 13.94% this year. The move comes as the beauty company pursues its &#8220;Beauty Reimagined&#8221; <a href="https://www.benzinga.com/25/05/45179419/estee-lauders-beauty-gains-cant-offset-global-headwinds-says-analyst">recovery strategy amid global headwinds</a>.
EL stock closed at $63.67 on Thursday, down 0.69% for the day. In after-hours trading, the stock rose 3.85% to $66.12, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
The 13F report revealed significant portfolio adjustments, including Scion taking a substantial bearish position on artificial intelligence leader NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) through 900,000 put options. NVIDIA shares have retreated from their January all-time high of $153.13 amid macroeconomic concerns and worries about tariff impacts.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45460177/bitcoin-rises-while-ethereum-dogecoin-slip-market-isnt-going-to-peak-in-the-next-6-months-says-popular-analyst">Bitcoin Rises While Ethereum, Dogecoin Slip — &#8216;Market Isn&#8217;t Going To Peak In The Next 6 Months,&#8217; Says Popular Analyst</a>
Why It Matters: Burry also completely liquidated his positions in Chinese tech companies, including Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), Baidu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), JD.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), and PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>). 
This exit coincides with President Donald Trump&#8216;s April announcement of hefty import tariffs targeting China, though both nations recently agreed to <a href="https://www.benzinga.com/25/04/44946516/goldman-sachs-ceo-says-trumps-90-day-tariff-pause-increased-the-level-of-uncertainty-triggered-market-repricing">suspend reciprocal levies for 90 days</a>.
The hedge fund manager also exited healthcare positions in HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), Oscar Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>), and Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>).
Analysts note that while Estée Lauder delivered <a href="https://www.benzinga.com/25/05/45179419/estee-lauders-beauty-gains-cant-offset-global-headwinds-says-analyst">stronger-than-expected third quarter earnings</a> with improved margins and cost control, the company still faces challenges, particularly in Asia travel retail and a softening North American market.
Photo Courtesy: Sorbis On Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45459474/sounds-familiar-mohamed-el-erian-calls-out-powells-deja-vu-on-supply-shocks-economist-draws-historic-parallels-on-fed-chairs-latest-message">&#8216;Sounds Familiar?&#8217; Mohamed El-Erian Calls Out Powell&#8217;s Déjà Vu On Supply Shocks—Economist Draws Historic Parallels On Fed Chair&#8217;s Latest Message</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

BABA

BIDU

OSCR

Citigourp Global Markets 2% Protected Notes Linked To The Djia

'The Big Short' Fame Michael Burry Doubled Estée Lauder Stake Despite Slump, Bet Against Nvidia And Dumps China Stocks Amid Trade War Jitters In Q1

Press Releases

Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital

Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

Comments

Lyra Therapeutics

Lyra Therapeutics (LYRA) Options

Lyra Therapeutics (NASDAQ:LYRA) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL